MGP and chronic kidney disease: These pro-osteogenic markers are balanced by inhibitors of calcification including MGP, osteopontin, BMP-7, and fetuin A.33Decreased fetuin A and MGP levels are both found in CKD patients and low levels of inhibitors in patients are associated with increased risk of death.34